| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 30.347 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 30.347 | 0 | 0 | 0 | 0 | 0 | 8.656 | 0 |
| Total Expenses - EUR | - | - | 1.087 | 3.454 | 4.363 | 3.385 | 3.084 | 344 | 556 | 0 |
| Gross Profit/Loss - EUR | - | - | 29.260 | -3.454 | -4.363 | -3.385 | -3.084 | -344 | 8.100 | 0 |
| Net Profit/Loss - EUR | - | - | 28.349 | -3.454 | -4.363 | -3.385 | -3.084 | -344 | 6.800 | 0 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dimareact Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 12.296 | 9.695 | 6.338 | 3.109 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 75.147 | 28.921 | 15.483 | 15.091 | 14.725 | 14.771 | 22.131 | 22.007 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 74.039 | 28.715 | 15.193 | 14.905 | 14.575 | 14.620 | 14.576 | 14.494 |
| Cash | - | - | 1.109 | 206 | 290 | 186 | 150 | 151 | 7.555 | 7.513 |
| Shareholders Funds | - | - | 28.393 | 24.418 | 19.582 | 15.826 | 12.391 | 12.086 | 18.848 | 18.743 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 15.358 | 14.235 | 2.331 | 2.374 | 2.334 | 2.686 | 3.282 | 3.264 |
| Income in Advance | - | - | 43.692 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7111 - 7111" | |||||||||
| CAEN Financial Year |
7111
|
|||||||||
Comments - Dimareact Lab Srl